Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | TXMD TherapeuticsMD, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $2.03 +0.0% | $15.90 -2.5% |
| StockIQ Score | 43D Weak Risk: Medium | 41D Weak Risk: High |
| Technical | 24F | 36F |
| Fundamental | 25F | 35F |
| Growth | 74B | 50C- |
| Fair Value | 50C- | 38F |
| News | 50C- | 50C- |
| Quality | 58C | 50C- |
| Risk | 48D+ | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
TXMD outperforms AAPG in growth, scoring 74 compared to AAPG’s 50, showing stronger potential for expansion. However, AAPG has a slightly higher technical score (36 vs. 24) and valuation score (38 vs. 50), indicating better short-term price trends and relative affordability. Both carry a "WEAK" rating, but TXMD’s growth advantage is its clear standout.
